We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

116 hedge funds and large institutions have $1.36B invested in IVERIC bio, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 9

83% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 23

26% more funds holding

Funds holding: 92 → 116 (+24)

20% more capital invested

Capital invested by funds: $1.13B → $1.36B (+$228M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

40% less call options, than puts

Call options by funds: $2.92M | Put options by funds: $4.84M

Holders
116
Holders Change
+24
Holders Change %
+26.09%
% of All Funds
3.09%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
34
Increased
42
Reduced
23
Closed
9
Calls
$2.92M
Puts
$4.84M
Net Calls
-$1.92M
Net Calls Change
-$1.24M

Top Buyers

1
O
OrbiMed
New York
+$22M
2
BFA
BlackRock Fund Advisors
California
+$18.7M
3
Morgan Stanley
Morgan Stanley
New York
+$15.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M
5
JCG
JHL Capital Group
Illinois
+$8.19M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$41.8M
2
SHI
SV Health Investors
Massachusetts
-$28.9M
3
RCM
RA Capital Management
Massachusetts
-$11.7M
4
GPP
Great Point Partners
Connecticut
-$11.7M
5
PA
Perceptive Advisors
New York
-$3.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$4.33M -$1.09M -26,059 -21%
TCIM
27
TIAA CREF Investment Management
New York
$4.31M +$1.21M +28,799 +43%
MAA
28
Managed Account Advisors
New Jersey
$4.29M +$44.3K +1,054 +1%
CCMU
29
Cheyne Capital Management (UK)
United Kingdom
$4.11M +$1.74M +41,443 +83%
American Century Companies
30
American Century Companies
Missouri
$4.07M +$3.81M +90,646 New
Axa
31
Axa
France
$3.99M +$239K +5,695 +7%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$3.68M +$135K +3,222 +4%
Invesco
33
Invesco
Georgia
$3.67M +$3.44M +81,817 New
HCA
34
Hillview Capital Advisors
Pennsylvania
$3.58M +$3.35M +79,830 New
Marshall Wace
35
Marshall Wace
United Kingdom
$3.07M +$2.88M +68,470 New
Franklin Resources
36
Franklin Resources
California
$3M +$2.81M +66,812 New
AP
37
AlpInvest Partners
Netherlands
$2.94M -$689K -16,410 -20%
GTC
38
Ghost Tree Capital
New York
$2.92M +$2.73M +65,000 New
IAS
39
IMA Advisory Services
Colorado
$2.92M +$2.73M +64,990 New
Wellington Management Group
40
Wellington Management Group
Massachusetts
$2.67M +$2.5M +59,468 New
EI
41
EAM Investors
California
$2.61M +$803K +19,125 +49%
AllianceBernstein
42
AllianceBernstein
Tennessee
$2.4M – – –
TG
43
TCW Group
California
$2.25M +$129K +3,082 +7%
BA
44
BlackRock Advisors
Delaware
$1.78M +$1.38M +32,781 +481%
CS
45
Credit Suisse
Switzerland
$1.74M +$1.25M +29,813 +334%
BIM
46
BlackRock Investment Management
Delaware
$1.68M -$20.2K -482 -1%
BBA
47
Baker Bros. Advisors
New York
$1.65M – – –
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$1.49M +$316K +7,528 +29%
ROTUOC
49
Regents of the University of California
California
$1.45M – – –
Citadel Advisors
50
Citadel Advisors
Florida
$1.43M +$903K +21,508 +208%
1
2
3 4 5

ISEE Hedge Fund Activity: Q4 2014 in Review

116 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2014, worth a combined $1.36B — up 20% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ISEE positions and 9 closed out — a net gain of 25 holders — while 42 added to existing stakes and 23 trimmed.

The largest buyer was OrbiMed, adding an estimated $22M. The largest seller was Novo Holdings A/S, cutting an estimated $41.8M.

  • 116 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2014, up from 92 in Q3 2014.
  • Funds reported $1.36B of IVERIC bio, Inc. Common Stock stock for Q4 2014, up 20% quarter-over-quarter.
  • 34 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2014 and 9 closed out, a net change of +25 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2014 was OrbiMed, an estimated $22M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2014 was Novo Holdings A/S, an estimated $41.8M sold.

Based on aggregated 13F filings for Q4 2014.